Bnp Paribas Asset Management Holding S.A. Avidity Biosciences, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 822 shares of RNA stock, worth $38,050. This represents 0.0% of its overall portfolio holdings.
Number of Shares
822Holding current value
$38,050% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RNA
# of Institutions
245Shares Held
116MCall Options Held
289KPut Options Held
998K-
Janus Henderson Group PLC London, X011.4MShares$529 Million0.19% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.3MShares$525 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$448 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.24MShares$428 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.75MShares$405 Million4.23% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.41B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...